Subscribe To
Fed's bostic: we are in a phase where there is some risk of overtightening
Baseline is no rate cuts until the second half of 2024 at earliestInflation is unacceptably high but there has been significant progressData consisten...
August 1, 2023, 7:37 pm
Medicenna: presenting data next week plus a clinical update next quarter
MDNA failed to report data from the fifth dosing cohort, of its phase 1/2 ABILITY study of MDNA11, in Q...
August 1, 2023, 3:49 pm
Zenas biopharma announces publication of phase 2 study of obexelimab, an investigational treatment for igg4-related disease (igg4-rd), in the lancet rheumatology
Study found obexelimab produced rapid, strong, and sustained clinical improvement, including complete clinical remission, in most patients with active...
August 1, 2023, 12:23 pm
Altimmune announces initiation of phase 2b impact trial evaluating the efficacy and safety of pemvidutide in non-alcoholic steatohepatitis (nash)
GAITHERSBURG, Md., Aug. 01, 2023 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that ...
August 1, 2023, 11:30 am
Uber achieves first-ever operating profit on record ridership in 2q
Uber Technologies Inc (NYSE:UBER) recorded its first-ever operating profit after ridership increased to record levels in its second quarter. The ride ...
August 1, 2023, 8:56 am
Travel enters a new phase. pick hilton and hotel peers over airbnb, analysts say.
Melius Research analysts start coverage of Hilton, Hyatt and Marriott with Buy ratings but are more cautious on Airbnb and Expedia....
August 1, 2023, 6:40 am
Santander wants to ride brazil's next wave
Brazil's economy is showing signs of recovery, with banks expected to benefit from an anticipated interest rate cut and a state-sponsored debt renegot...
August 1, 2023, 3:17 am
Point biopharma: stock has upcoming catalysts with 2 therapies in phase 3 trials
POINT Biopharma has two therapies in phase 3 development with fast track designation, which creates the...
August 1, 2023, 12:23 am
Anaptysbio- and gsk-partnered immuno-oncology agent jemperli (dostarlimab-gxly) plus chemotherapy approved in the u.s. for dmmr/msi-h primary advanced or recurrent endometrial cancer
JEMPERLI is the first immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy U.S. Fo...
July 31, 2023, 5:34 pm
Spero therapeutics shares rise on fda approval of pivotal complicated uti trial
Spero Therapeutics shares soared after the clinical-stage biopharmaceutical company announced that it has received special protocol approval from the ...
July 31, 2023, 3:42 pm
Enphase energy: still buying as international markets outperform the domestic market
The US remains a weak market for the company as sell-through was weaker than expected, as a result of high interest rates, leading to an elevated inve...
July 31, 2023, 2:55 pm
Spero therapeutics announces special protocol assessment agreement with fda for phase 3 pivot-po trial of tebipenem hbr
phase 3 PIVOT-PO trial is expected to begin with First Patient, First Visit in 4Q 2023 Spero to receive...
July 31, 2023, 12:05 pm
Royal mail's old-style stamps reach return deadline
Non-barcoded stamps will become invalid once the clock strikes midnight this evening, as Royal Mail phases out the use of the traditio...
July 31, 2023, 11:09 am
Bt's new boss backs strategy so is it more of the same?
The City gave a lukewarm welcome to Allison Kirkby's appointment as chief executive of BT Group PLC (LSE:BT.A) as she gave her backing to the existing...
July 31, 2023, 7:33 am
How will the eur/usd react to this week’s monetary policy meetings?
Between July 6th and July 17th, the EUR/USDshowed a remarkable upward trend, soaring from 1.08536 to 1.12484. Yet, the tides have shifted since then, ...
July 31, 2023, 4:00 am
Bitcoin falls below $30,000 but this new coin is doing wonders in the presale phase
Bitcoin has fallen below the $30,000 mark. This value drop is now reflected in the prices of several other digital assets. Read Full Story The post Bi...
July 30, 2023, 3:14 pm
Tg therapeutics: addressing the sc ocrevus concern
The launch of Briumvi is off to a solid start, but the stock pulled back recently and fell more after Roche reported positive ...
July 29, 2023, 9:50 pm
The cryptocurrency market digest (btc, sol). overview for 28.07.2023
By RoboForex.com The BTC rate on Friday stood at approximately 29,229 USD. Each new attempt by BTC to rise becomes increasingly difficult. The overall...
July 28, 2023, 2:25 pm
Enph stock alert: enphase energy just hit a new 52-week low
Struggling for traction throughout this year, solar energy specialist Enphase Energy (NASDAQ: ENPH ) su...
July 28, 2023, 1:20 pm
Enphase energy slumps on 2q sales miss; weak guidance
Enphase Energy Inc (NASDAQ:ENPH) shares fell sharply on Friday after it reported second-quarter revenu...
July 28, 2023, 1:01 pm